Research Progress of Immunotherapy for Pancreatic Malignant Tumors

胰腺恶性肿瘤恶性程度高，其死亡率与发病率紧密匹配，尽管近年来的诊疗策略不断进步，但总体预后并没有一个显著的改善。免疫治疗作为新兴的治疗策略，为胰腺恶性肿瘤患者提供了新的治疗思路，并且在部分临床研究中表现出明显的优势。尽管目前仍有诸多局限，但潜力巨大，为胰腺恶性肿瘤患者带来新的曙光。Pancreatic malignant tumors are highly malignant, and their mortality and morbidity are closely matched. Although the diagnosis and treatment strategies have been continuously improved in recent years, the overall prognosis has not been significantly improved. As an emerging treatment strategy, immunotherapy provides new treatment ideas for patients with pancreatic malignant tumors and has shown obvious advantages in some clinical studies. Although there are still many limitations, it has great potential to bring a new dawn to patients with pancreatic cancer.